Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Paravertebral Catheter vs PCA for Pain Control in VATS
NCT02361775Phase 1Completed
- Sponsor
- University of Minnesota
- Start
- Jul 2012
- Primary completion
- Oct 2014
- Modality
- Targeted Liposomes, Stealth (PEGylated) Liposomes, Conventional Liposomes
01
Overview
Phase 1, randomised, open-label trial of ropivacaine hydrochloride liposomal suspension injection in postoperative pain (2 arms), sponsored by University of Minnesota. Primary endpoint: Maximum NRS Pain score. Started Jul 2012; status: completed.
02
Drugs
ropivacaine hydrochloride liposomal suspension injection
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT02361775.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02361775.